Patent · US Active

Treatment of demyelinating diseases

US10898495B2 · kind B2 · utility

1Cited by

11References

13Claims

0Family size

Assignee

M et P Pharma AG · CH

Inventors

Claudia Mattern · Starnberg, DE
Elisabeth Traiffort · Paris, FR
Michael Schumacher · Ironwood, US

Key dates

Filing date	Mar 11, 2020
Grant date	Jan 26, 2021
Priority date	—
Expiry date	Mar 11, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/506
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.